FDA & EMA Grant Orphan Drug Status to Bioxodes’ St...
Category : ODD/BTA/FTA Status 7 March 2025Bioxodes SA, a clinical stage biopharmaceutical company developing novel therapies for the preventio...
Odd Bta Fta Status
FDA Grants Fast Track Status to Latigo’s LTG-001 f...
Category : ODD/BTA/FTA Status 5 March 2025Latigo Biotherapeutics (Latigo), a private clinical-stage biotechnology company, announced the US Fo...
FDA Grants Breakthrough Designation to Innate Phar...
Category : ODD/BTA/FTA Status 19 February 2025Innate Pharma SA, a global, clinical-stage biotechnology company developing immunotherapies for canc...
FDA Grants Fast Track to NKGen’s Natural Killer Th...
Category : ODD/BTA/FTA Status 17 February 2025NKGen Biotech, Inc, a clinical-stage biotechnology company focused on the development and commercial...
Beckman Coulter Gets FDA Breakthrough Status for A...
Category : ODD/BTA/FTA Status 30 January 2025Beckman Coulter Diagnostics, a global leader in clinical diagnostics, announced the US Food and Drug...
Latest Newsletter Post
-
IASO Bio Secures NDA Approval on Eq..
29 March 2025
-
US FDA grants fast track designatio..
29 March 2025
-
Bayer, Puhe BioPharma Ink Global Li..
29 March 2025
-
SKB107 Wins China NMPA Nod for Bone..
29 March 2025
-
AdjuTec Pharma, Venus Remedies Part..
28 March 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com